Regulatory hurdles - SAMR

According to a note out of Goldman Sachs this morning, it has held firm with its neutral rating and $9.00 price target.

These hurdles will make the rise of BAL so much steeper when the inevitable approvals occur.

I like when A2M posters bring doom to the BAL forum.
The shorters are going to regret their positions come SAMR and site visits could happen any day. That gives shorters 5 months max to exit.

When BAL receives an unexpected SAMR registration, shorters still upped their assault. I can see the pending expected SAMR will bring their undoing.

We all have a choice, hold, watch, short or sell. Watch, short or sell if you expect downside. Buy if you think site visits are near. It is really simple IMO.